SMLE pediatrics questions

Pneumatosis intestinalis appears on abdominal radiograph as linear or cystic lucencies within the bowel wall, caused by gas produced by bacteria invading the ischemic/necrotic intestinal wall. It is a hallmark radiographic finding of necrotizing enterocolitis (NEC) in a preterm infant with feeding intolerance, bloody stools, and signs of sepsis. Other supportive findings include portal venous gas and, in advanced disease, pneumoperitoneum from perforation. This infant's prematurity, bilious vomiting, and bloody stools fit the clinical picture of NEC, and the radiograph is used to confirm bowel wall involvement.

• A. A single dilated loop with air-fluid level is nonspecific and not characteristic of NEC.
• B. Double bubble sign indicates duodenal atresia, not NEC.
• C. A ground-glass gasless abdomen suggests meconium ileus or severe ascites, not NEC.

Ampicillin plus gentamicin is the standard empiric regimen for early-onset neonatal sepsis because it covers the most common causative organisms, Group B Streptococcus and Escherichia coli, as well as Listeria monocytogenes. Ampicillin provides activity against GBS and Listeria, while gentamicin provides synergistic aminoglycoside coverage against Gram-negative organisms and broadens coverage against resistant strains. Ceftriaxone is generally avoided in neonates due to the risk of biliary sludging and displacement of bilirubin from albumin, increasing kernicterus risk, and lacks Listeria coverage. This regimen is recommended by major neonatal guidelines including those followed in Saudi MOH neonatal units.

• A. Ceftriaxone can displace bilirubin from albumin and cause biliary sludging in neonates, and metronidazole is not indicated unless anaerobic infection is suspected.
• B. Vancomycin and meropenem are reserved for late-onset sepsis with suspected resistant organisms or nosocomial infection, not first-line for early-onset sepsis.
• D. Cloxacillin and amikacin do not provide adequate coverage against Listeria and Gram-negative organisms as the standard regimen does.

Chronic maternal hyperglycemia exposes the fetus to high glucose levels, stimulating fetal pancreatic beta-cell hyperplasia and increased fetal insulin secretion in utero. After delivery, the maternal glucose supply is abruptly cut off, but the neonate's beta cells continue to secrete insulin excessively for a period, causing profound hypoglycemia. This hyperinsulinemic state also explains the associated macrosomia, as insulin acts as a fetal growth factor. Hypoglycemia typically appears within the first few hours of life and resolves as the neonatal hyperinsulinemic state subsides.

• A. Glucagon secretion is not the primary defect; the problem is excess insulin, not deficient glucagon.
• B. Placental glucose transfer is increased, not reduced, in maternal hyperglycemia, contributing to fetal hyperinsulinemia.
• D. Maternal hyperglycemia actually increases fetal glycogen stores through excess glucose and insulin, not impairs it.

This infant's phenotype, upslanting palpebral fissures, flat nasal bridge, single palmar crease, and hypotonia, is classic for Down syndrome, most commonly caused by trisomy 21 from nondisjunction during meiosis, resulting in an extra free chromosome 21 in all cells. Atrioventricular septal defect (AV canal defect) is the most characteristic congenital heart lesion associated with Down syndrome, resulting from abnormal development of the endocardial cushions. Standard trisomy 21 (nondisjunction) accounts for about 95% of Down syndrome cases, while translocation Down syndrome is less common. Echocardiography is essential in all newborns with suspected Down syndrome given the high prevalence of congenital heart disease.

• A. A balanced translocation involving chromosomes 13 and 14 is a Robertsonian translocation pattern associated with translocation Down syndrome, which is much less common than free trisomy 21 and would not be the most likely karyotype finding overall.
• C. Monosomy X describes Turner syndrome, which presents with different features such as webbed neck and does not match this phenotype.
• D. Chromosome 5 long arm deletion causes cri-du-chat syndrome, characterized by a high-pitched cat-like cry, not this phenotype.

This girl's short stature, webbed neck, widely spaced nipples, broad chest, primary amenorrhea, hypertension (suggesting coarctation of the aorta), and lymphedema of the lower limbs are classic features of Turner syndrome, caused by complete or partial loss of one X chromosome. The most common karyotype is 45,X (monosomy X) due to nondisjunction or loss of a sex chromosome, though mosaic patterns such as 45,X/46,XX also occur. Associated findings include gonadal dysgenesis with streak ovaries, leading to primary amenorrhea and estrogen deficiency, and an increased risk of coarctation of the aorta and bicuspid aortic valve. Hypertension in a girl with these features should prompt evaluation for coarctation.

• B. 46,XY is a normal male karyotype and would not explain this patient's female phenotype with these features.
• C. 47,XXX (triple X syndrome) in females is usually phenotypically unremarkable and does not cause this constellation of features.
• D. 47,XXY is the karyotype of Klinefelter syndrome, which occurs in males with tall stature and hypogonadism, not this phenotype.

Fragile X syndrome is caused by an expansion of CGG trinucleotide repeats in the 5' untranslated region of the FMR1 gene on the X chromosome, typically exceeding 200 repeats in affected individuals. This expansion leads to hypermethylation of the FMR1 promoter, silencing transcription and resulting in loss of FMRP, a protein important for synaptic development. The X-linked inheritance with repeat expansion explains the family history of an affected maternal uncle, since the mutation can expand through maternal transmission. Clinical features include intellectual disability, long face, large ears, macro-orchidism after puberty, and autistic features.

• B. A dystrophin gene mutation causes Duchenne muscular dystrophy, which presents with progressive muscle weakness, not this phenotype.
• C. Microdeletion at 7q11.23 causes Williams syndrome, which presents with a different facial and behavioral phenotype.
• D. SHOX gene deletion causes short stature conditions such as Leri-Weill dyschondrosteosis, not this phenotype.

Newborn metabolic screening is performed via a heel-prick capillary blood sample collected ideally between 24 and 72 hours of life, after feeding has been established, to detect conditions such as congenital hypothyroidism, phenylketonuria, and other inborn errors of metabolism before clinical symptoms appear. Early detection allows prompt treatment, which can prevent irreversible complications such as intellectual disability in congenital hypothyroidism or PKU. Testing too early (before 24 hours) risks false results due to incomplete metabolic adaptation, while delaying screening risks missed early intervention windows. This screening is a core part of Saudi MOH newborn care protocols and is distinct from chromosomal or structural anomaly screening.

• A. Newborn metabolic screening uses a heel-prick capillary sample, not venous blood, and screens for metabolic/endocrine disease, not chromosomal abnormalities.
• B. Metabolic screening is done shortly after birth, not at 2 weeks, and it screens for metabolic/endocrine disorders, not structural anomalies.
• D. Delaying screening to 6 weeks would miss the critical early window for detecting and treating conditions like congenital hypothyroidism and PKU before irreversible damage occurs.

A single intramuscular dose of vitamin K1 (phytonadione) 1 mg given within hours of birth is the standard, most effective regimen for preventing early, classic, and late vitamin K deficiency bleeding, because breast milk is low in vitamin K and neonatal gut flora and hepatic stores are insufficient. Intramuscular administration provides a depot effect with sustained absorption over weeks, unlike oral dosing, which has lower and more variable bioavailability and requires multiple doses with poorer compliance. This practice is recommended by the American Academy of Pediatrics, WHO, and Saudi MOH newborn care protocols. Oral regimens are reserved for settings where parents refuse injection, with counselling on inferior efficacy.

• A. Oral dosing is less effective than IM and is only a second-line option when parents refuse injection.
• C. Vitamin D does not prevent vitamin K deficiency bleeding; this addresses a different deficiency.
• D. Phytonadione is not given as a daily IM course; this is not a recognized regimen.

MMR is a live attenuated vaccine and is contraindicated in children with significant immunosuppression from chemotherapy, because viral replication can be uncontrolled and cause disseminated, potentially fatal disease. Live vaccines should be deferred until the child has completed chemotherapy and immune function has recovered, typically confirmed by hematology and guided by CDC/ACIP and Saudi MOH immunization guidelines for immunocompromised hosts, generally at least 3 months after stopping immunosuppressive therapy. Household contacts should still receive MMR to reduce exposure risk to the patient. Inactivated vaccines can generally still be given but may have reduced immunogenicity during chemotherapy.

• B. There is no inactivated substitute for MMR; the correct action is to defer the live vaccine, not replace it.
• C. IVIG does not make a live vaccine safe to give and can also blunt vaccine immune response.
• D. Giving a live vaccine during active chemotherapy risks vaccine-strain disseminated disease and is contraindicated.

This child has fever for ≥5 days plus 4 of the classic principal features (conjunctival injection, mucocutaneous changes, rash, cervical lymphadenopathy), consistent with Kawasaki disease. Extremity changes, including erythema and edema of the palms and soles in the acute phase and periungual desquamation later, are one of the five principal clinical criteria used alongside fever duration to diagnose classic Kawasaki disease. Diagnosis is clinical, as no specific laboratory test exists. Recognizing these criteria early is essential because untreated Kawasaki disease carries a 15-25% risk of coronary artery aneurysm.

• A. Koplik spots are pathognomonic for measles, not Kawasaki disease.
• C. Parotid swelling suggests mumps, not a principal feature of Kawasaki disease.
• D. A dermatomal vesicular rash suggests varicella-zoster infection, not Kawasaki disease.

The standard treatment for acute Kawasaki disease is a single infusion of IVIG 2 g/kg given over 10-12 hours, combined with aspirin, started ideally within 10 days of fever onset to maximize efficacy. High-dose aspirin (80-100 mg/kg/day divided) is used during the acute febrile phase for its anti-inflammatory effect, then switched to low-dose aspirin (3-5 mg/kg/day) once afebrile for its antiplatelet effect, continued until normalization of inflammatory markers and coronary arteries. This combination reduces the incidence of coronary artery aneurysm from about 25% to under 5%. Timely administration before day 10 of illness is critical to prevent coronary complications.

• A. Antibiotics have no role since Kawasaki disease is not a bacterial infection.
• C. Starting directly with low-dose aspirin omits the anti-inflammatory high-dose phase needed during the acute illness.
• D. Corticosteroids are not first-line therapy and are reserved for IVIG-resistant cases or added in high-risk scoring systems, not as monotherapy.

In neonates (0-28 days), empiric therapy for bacterial meningitis must cover group B Streptococcus, Escherichia coli and other gram-negative organisms, and Listeria monocytogenes. Ampicillin provides Listeria coverage, which cephalosporins alone do not, while cefotaxime provides reliable gram-negative and CNS penetration without the risk of bilirubin displacement seen with ceftriaxone in neonates. Ceftriaxone is avoided in neonates, especially premature or jaundiced infants, due to risk of biliary sludging and kernicterus from albumin-bound bilirubin displacement. This combination is the standard empiric regimen recommended for neonatal bacterial meningitis.

• B. Gentamicin has poor CNS penetration and is not sufficient as the sole gram-negative/CNS agent for meningitis.
• C. Ceftriaxone is contraindicated in neonates because of the risk of bilirubin displacement and kernicterus; vancomycin does not cover Listeria.
• D. Metronidazole covers anaerobes, which are not relevant pathogens in neonatal meningitis.

This is a simple febrile seizure: generalized, lasting less than 15 minutes, non-recurrent within 24 hours, occurring in a neurologically normal child aged 6 months to 5 years. Simple febrile seizures carry an excellent prognosis and do not require EEG, neuroimaging, or routine lumbar puncture unless there are signs of meningitis, prolonged postictal state, or the child is under 12 months with incomplete immunization. Management focuses on identifying and treating the source of fever and reassuring the family about the benign nature and low risk of epilepsy. Antiepileptic therapy is not indicated after a single simple febrile seizure.

• A. Lumbar puncture is reserved for signs of meningitis or encephalopathy, not performed routinely in a well-appearing child after a simple febrile seizure.
• B. EEG is not indicated after a simple febrile seizure with a normal neurological exam and rapid return to baseline.
• D. Maintenance antiepileptics are not used for simple febrile seizures, which have a benign prognosis.

This presentation of rhinorrhea, cough, tachypnea, and bilateral wheezing with crackles in an infant under 2 years during winter is classic for viral bronchiolitis, most commonly caused by respiratory syncytial virus. Management for mild to moderate cases with adequate oxygenation and feeding is purely supportive, including nasal suctioning, ensuring hydration, and antipyretics if needed, since bronchodilators, corticosteroids, and antibiotics have not been shown to improve outcomes in uncomplicated bronchiolitis. Routine chest radiography is not recommended as it does not change management and may lead to unnecessary antibiotic use. Current guidelines, including those from the American Academy of Pediatrics, emphasize supportive care as the mainstay of bronchiolitis management in most patients.

• A. Chest radiograph and antibiotics are unnecessary in typical viral bronchiolitis without signs of bacterial superinfection or respiratory distress.
• B. Ribavirin is not routinely recommended and is reserved for select severe cases in immunocompromised patients, not for typical mild bronchiolitis.
• D. Bronchodilators and corticosteroids have not shown consistent benefit in bronchiolitis and are not recommended as routine therapy.

This child has moderate-to-severe croup, with stridor at rest, marked retractions, and decreased air entry. Nebulized epinephrine (racemic or L-epinephrine) rapidly reduces airway mucosal edema via alpha-adrenergic vasoconstriction and is indicated for moderate to severe croup regardless of prior steroid dosing. Because the effect lasts only 1-2 hours and rebound stridor can occur, patients must be observed for at least 2-3 hours after treatment before discharge is considered. Dexamethasone has a delayed onset of action, so epinephrine bridges the gap during the acute severe phase.

• A. Discharge is unsafe at this severity without treating the acute airway obstruction and observing the response.
• B. Bronchoscopy is not indicated for typical viral croup and is reserved for suspected foreign body or structural airway anomaly.
• C. Croup is viral; antibiotics are not indicated unless bacterial tracheitis is suspected.

The tripod positioning, drooling, muffled 'hot potato' voice, high fever, and toxic appearance without a barky cough are classic for acute epiglottitis, most often caused by Haemophilus influenzae type b in unimmunized children. This is an airway emergency: the child should not be examined with a tongue depressor or laid supine, as this can precipitate complete airway obstruction. Management requires immediate involvement of anesthesia and ENT for controlled airway visualization and intubation in the operating room, followed by IV antibiotics.

• A. Croup typically causes a barky cough and hoarse voice with a more gradual, less toxic presentation, which is absent here.
• C. Retropharyngeal abscess typically causes neck stiffness and torticollis rather than the classic tripod drooling presentation.
• D. Bacterial tracheitis usually follows a preceding viral croup illness with a brassy cough, not the acute tripod/drooling picture.

This child has uncontrolled asthma on low-dose inhaled corticosteroid (ICS) monotherapy despite good adherence and technique, meeting criteria for step-up therapy per GINA pediatric guidelines. The preferred step-up for children is to add a long-acting beta-2 agonist (LABA) to the low-dose ICS, forming combination therapy that improves control while avoiding the adverse effects of higher steroid doses. LABA monotherapy is never used, and oral corticosteroids are reserved for severe exacerbations, not maintenance therapy at this stage.

• A. Long-term oral corticosteroids carry significant systemic side effects and are reserved for severe, refractory asthma as a last resort.
• B. Jumping to high-dose ICS monotherapy increases the risk of growth suppression and adrenal suppression without first trying combination therapy.
• D. Leukotriene receptor antagonists are less effective than ICS-LABA combination and are not the preferred step-up option.

A harsh, holosystolic (pansystolic) murmur loudest at the left lower sternal border in an otherwise asymptomatic infant is characteristic of a small to moderate ventricular septal defect (VSD), caused by turbulent flow across the defect during systole as blood shunts left to right. Small VSDs are often hemodynamically insignificant and may close spontaneously within the first two years of life, so asymptomatic infants with normal growth are typically managed with observation and serial echocardiography. The absence of radiation to the back and normal femoral pulses help distinguish it from other lesions.

• A. Atrial septal defect typically produces a soft systolic ejection murmur at the upper left sternal border with a fixed split S2, not a harsh holosystolic murmur.
• C. Pulmonary valve stenosis produces a systolic ejection murmur at the upper left sternal border, often with radiation to the back, not a holosystolic murmur at the lower sternal border.
• D. Patent ductus arteriosus classically causes a continuous 'machinery' murmur rather than an isolated holosystolic murmur.

This is a hypercyanotic ('tet') spell, triggered by crying or agitation that increases pulmonary vascular resistance and worsens right-to-left shunting across the VSD, causing the murmur to soften as flow across the obstructed right ventricular outflow tract decreases. The knee-chest position (or squatting in older children) increases systemic vascular resistance and venous return, reducing the right-to-left shunt and improving pulmonary blood flow, and should be done immediately along with supplemental oxygen. If this fails, further measures include morphine, IV fluids, and phenylephrine to raise systemic vascular resistance.

• B. Bronchodilators treat airway obstruction, not the cardiac right-to-left shunting responsible for this spell.
• C. Echocardiography is useful for diagnosis but does not address the acute physiological crisis and would delay life-saving positioning.
• D. Furosemide is used for heart failure with volume overload, not for relieving dynamic right ventricular outflow tract obstruction in a tet spell.

A significant blood pressure gradient between the upper extremities (higher) and lower extremities (lower), combined with weak, delayed femoral pulses radial-femoral delay and an interscapular systolic murmur, is the classic finding of coarctation of the aorta. This narrowing, usually just distal to the left subclavian artery near the ductus arteriosus, obstructs flow to the descending aorta, reducing perfusion pressure to the lower body. Infants presenting in the neonatal period with duct-dependent coarctation can develop acute heart failure and shock as the ductus arteriosus closes, requiring prompt diagnosis and prostaglandin E1 infusion to maintain ductal patency until surgical repair.

• A. Pulmonary valve stenosis causes an ejection murmur at the upper left sternal border without a limb blood pressure differential.
• B. Patent ductus arteriosus causes a continuous murmur and bounding pulses, not a blood pressure gradient between upper and lower limbs.
• C. Atrial septal defect does not cause differential blood pressure or pulse findings between the upper and lower extremities.

The ductus arteriosus is kept patent in utero and in the early neonatal period mainly by locally produced prostaglandin E2, which maintains smooth muscle relaxation. Indomethacin (and ibuprofen) are nonselective cyclooxygenase inhibitors that block the conversion of arachidonic acid to prostaglandins, lowering circulating PGE2 levels and allowing ductal smooth muscle to constrict and the ductus to close. This pharmacologic effect is most reliable in preterm infants, since ductal tissue sensitivity to prostaglandins decreases with increasing gestational maturity. COX inhibition also explains the main toxicities of these drugs: reduced renal and mesenteric blood flow and platelet dysfunction.

• A. Calcium channel blockade is not the mechanism of indomethacin and is not used for ductal closure.
• C. Indomethacin inhibits, rather than stimulates, pathways that keep the ductus open; nitric oxide stimulation would favor patency, not closure.
• D. Endothelin receptor blockade is unrelated to indomethacin's action and is not a recognized therapy for PDA.

This infant's presentation, non-bilious projectile vomiting with a palpable olive-shaped mass and hypochloremic hypokalemic metabolic alkalosis, is classic for hypertrophic pyloric stenosis, caused by repeated vomiting of gastric hydrochloric acid and volume depletion that triggers renal potassium wasting to conserve sodium. Abdominal ultrasound is the imaging investigation of choice because it is non-invasive, avoids radiation, and directly visualizes the hypertrophied pyloric muscle; diagnostic criteria are typically a muscle wall thickness of 3-4 mm or more and a canal length of 15-17 mm or more. Electrolyte and acid-base correction should precede surgery (pyloromyotomy), as anesthesia in an alkalotic, hypokalemic infant risks postoperative apnea.

• A. Plain radiographs are nonspecific in pyloric stenosis and do not reliably demonstrate the pyloric muscle.
• C. A barium study can show the 'string sign' but exposes the infant to radiation and contrast aspiration risk, and has been replaced by ultrasound as the first-line test.
• D. CT is not indicated, involves radiation, and offers no advantage over ultrasound in this classic presentation.

This child has the classic triad of intermittent colicky abdominal pain, a palpable sausage-shaped abdominal mass, and red currant jelly stools, pointing to ileocolic intussusception, the most common cause of intestinal obstruction in children between 6 months and 3 years of age. Abdominal ultrasound is the investigation of choice, showing the characteristic target sign (concentric rings) or pseudokidney sign on cross-section, with sensitivity and specificity both exceeding 95%. Ultrasound also avoids radiation and can be followed immediately by therapeutic air or hydrostatic contrast enema reduction if there are no signs of perforation or peritonitis.

• A. CT can show intussusception but involves significant radiation exposure and is not needed when ultrasound is readily available and highly accurate.
• B. Colonoscopy is invasive, unnecessary for diagnosis, and risky in a child with suspected bowel obstruction or ischemia.
• D. Plain radiographs may show nonspecific obstruction or a soft tissue mass but lack the sensitivity and specificity of ultrasound for diagnosis.

Failure to pass meconium within 48 hours, abdominal distension, and the explosive release of stool on rectal examination (squirt sign) in a full-term infant are classic for Hirschsprung disease, caused by failure of neural crest cell migration leading to an aganglionic distal bowel segment. While contrast enema and anorectal manometry are useful supportive tests, rectal biopsy demonstrating absence of ganglion cells in the submucosal and myenteric plexuses, often with hypertrophied nerve trunks and increased acetylcholinesterase staining, remains the definitive diagnostic test. Suction rectal biopsy is preferred as the initial approach in neonates because it is less invasive than full-thickness biopsy.

• A. Sweat chloride testing diagnoses cystic fibrosis, which can cause meconium ileus but not the aganglionosis seen in this case.
• B. RET mutations are associated with some cases of Hirschsprung disease but genetic testing is not required for diagnosis and many cases are not linked to an identifiable mutation.
• C. Anorectal manometry is a useful screening tool but is technically difficult in neonates and is not the definitive diagnostic test.

Chronic diarrhea with bloating and faltering growth in a school-age child raises suspicion for celiac disease, an immune-mediated enteropathy triggered by gluten in genetically susceptible individuals. Anti-tissue transglutaminase IgA (anti-tTG IgA) is the recommended first-line serologic screening test, given its high sensitivity and specificity, provided total serum IgA is normal (as confirmed here), since IgA deficiency is more common in celiac disease and would cause a false negative. A positive result should be followed by duodenal biopsy showing villous atrophy, crypt hyperplasia, and intraepithelial lymphocytosis to confirm the diagnosis, unless strict ESPGHAN no-biopsy criteria with very high titers and positive endomysial antibody and HLA typing are met.

• A. Anti-Saccharomyces cerevisiae antibody is associated with Crohn disease, not celiac disease.
• B. Fecal calprotectin indicates intestinal inflammation and helps distinguish inflammatory bowel disease from functional disorders but is not specific for celiac disease.
• D. Anti-nuclear antibody is used in the evaluation of autoimmune connective tissue diseases, not celiac disease.

This child's presentation, edema, heavy proteinuria, hypoalbuminemia, normal blood pressure, and absence of hematuria in a preschool-age child, is typical of minimal change disease, the most common cause of nephrotic syndrome in children. Minimal change disease is highly steroid-responsive, with over 85-90% of children achieving complete remission within 4-8 weeks of oral corticosteroid therapy, which is why renal biopsy is typically deferred and empiric steroids are started first in this age group. This exceptional steroid responsiveness is itself a defining clinical feature used to support the diagnosis without biopsy confirmation. Relapses are common and may require repeated or prolonged steroid courses or steroid-sparing agents.

• B. Minimal change disease is not an immune complex-mediated disease; it is thought to involve T-cell dysfunction and podocyte injury without immune deposits on biopsy.
• C. ACE inhibitors reduce proteinuria by lowering intraglomerular pressure but are not the first-line disease-modifying therapy for minimal change disease in children.
• D. Aldosterone receptor blockade describes drugs like spironolactone, not corticosteroids, and is not the primary treatment for minimal change disease.

This boy's presentation fits post-streptococcal glomerulonephritis (PSGN), an immune complex-mediated glomerulonephritis that typically follows streptococcal pharyngitis after a latency period of 1-3 weeks (or 3-6 weeks after streptococcal skin infection), reflecting the time needed for antibody-antigen complex formation and deposition. The hallmark laboratory findings are an active urinary sediment with red cell casts and dysmorphic red blood cells, along with transient hypocomplementemia (low C3 with normal C4), since the alternative complement pathway is activated. C3 levels characteristically normalize within 6-8 weeks; persistence beyond 3 months should prompt evaluation for an alternative diagnosis such as membranoproliferative glomerulonephritis.

• A. Persistently low C3 beyond 3 months is not expected in typical PSGN and should raise suspicion for another glomerular disease.
• B. PSGN classically causes an active urinary sediment with hematuria and red cell casts and hypocomplementemia, not an isolated proteinuric picture with normal complement.
• D. Glomerulonephritis in PSGN develops after a latent period, not simultaneously with the streptococcal infection, reflecting the time required for immune complex formation.

Current guidelines (such as NICE and AAP, which inform Saudi pediatric practice) recommend that after a first febrile urinary tract infection with a normal renal and bladder ultrasound, no further routine imaging such as voiding cystourethrogram (VCUG) is required, since the main goal of imaging is to detect renal anomalies or scarring, not to identify vesicoureteral reflux in every child. VCUG is reserved for infants with atypical features (such as poor response to antibiotics, atypical organisms, abnormal ultrasound, or sepsis) or recurrent febrile UTIs, given its invasiveness and radiation exposure. A DMSA scan, if indicated, is used to assess for renal scarring and is performed weeks after the acute infection resolves, not during the acute illness, to avoid false-positive changes from acute inflammation.

• A. Routine VCUG for every infant after a first febrile UTI is no longer recommended given its invasiveness and radiation exposure when ultrasound is normal and there are no atypical features.
• C. Routine repeat ultrasound is not required when the initial scan is normal and there are no atypical features or recurrent infections.
• D. DMSA scanning during the acute illness is avoided because acute pyelonephritic changes can cause false-positive results; it is delayed by several months if performed at all.

The triad of microangiopathic hemolytic anemia (schistocytes, low haptoglobin, high LDH), thrombocytopenia, and acute kidney injury following a diarrheal prodrome (classically Shiga toxin-producing E. coli O157:H7) is diagnostic of typical hemolytic uremic syndrome. The toxin damages glomerular endothelial cells, triggering local platelet activation and microthrombi that mechanically shear red cells. Coagulation studies (PT, aPTT, fibrinogen) are typically normal, distinguishing it from DIC. Management is supportive, with antibiotics avoided as they may increase toxin release.

• B. Henoch-Schönlein purpura presents with palpable purpura, arthritis, and abdominal pain, not microangiopathic hemolysis.
• C. ITP causes isolated thrombocytopenia without anemia, schistocytes, or renal impairment.
• D. DIC would show prolonged PT/aPTT and low fibrinogen, which are not described here and are absent in typical HUS.

This presentation is a typical vaso-occlusive crisis, caused by sickled erythrocytes occluding microvasculature in the bone marrow, producing ischemic pain. The first priority is prompt, adequate analgesia, with intravenous opioids such as morphine being the standard for severe pain, alongside hydration and oxygen if hypoxic. Early effective analgesia improves outcomes and should not be delayed for extensive investigations when the clinical picture is classic. Antibiotics and imaging are reserved for evidence of infection or complications such as osteomyelitis or acute chest syndrome, which are not present here.

• A. Empiric antibiotics are indicated for suspected sepsis or osteomyelitis, which this afebrile child without localized signs does not have.
• B. Imaging is unnecessary for a classic painful crisis without focal swelling or suspicion of fracture or osteomyelitis and would delay analgesia.
• D. Exchange transfusion is reserved for severe complications like acute chest syndrome or stroke, not uncomplicated vaso-occlusive pain.

G6PD is the rate-limiting enzyme of the hexose monophosphate shunt, generating NADPH, which maintains reduced glutathione to neutralize oxidative stress within red blood cells. In G6PD deficiency, exposure to oxidant triggers (certain drugs, fava beans, infection) overwhelms this antioxidant defense, causing hemoglobin denaturation into Heinz bodies, membrane damage, and splenic removal of damaged cells (bite cells), producing acute hemolysis. This mechanism explains the drug- and infection-triggered pattern rather than a constant background hemolysis. Treatment is supportive, with avoidance of known oxidant triggers.

• A. Glutathione synthesis enzymes are intact in G6PD deficiency; the defect is in regenerating reduced glutathione via NADPH, not synthesizing it.
• C. Spectrin defects cause hereditary spherocytosis or elliptocytosis, not G6PD deficiency.
• D. Ferrochelatase deficiency causes a type of porphyria, unrelated to the oxidative hemolysis seen in G6PD deficiency.

Congenital hypothyroidism requires thyroid hormone for normal brain myelination and neuronal development, particularly in the first few months of life. Delay in starting levothyroxine replacement beyond this critical window, as occurs when newborn screening is missed, results in irreversible intellectual disability despite later treatment. This is why universal newborn screening programs, including in Saudi Arabia, test for congenital hypothyroidism within the first days of life, allowing treatment before neurological damage occurs. Other features such as hypotonia, macroglossia, and umbilical hernia may improve with treatment, but neurodevelopmental deficits from delayed diagnosis are permanent.

• A. Untreated congenital hypothyroidism causes delayed, not precocious, puberty and growth.
• B. Sensorineural hearing loss is not a typical complication of congenital hypothyroidism; it is more associated with Pendred syndrome, a specific genetic cause.
• C. Hypothyroidism is not a recognized cause of type 2 diabetes mellitus in children.

The combination of headache, deteriorating consciousness, bradycardia, and hypertension (Cushing's triad pattern) occurring hours into DKA treatment is characteristic of cerebral edema, a feared complication most often linked to rapid correction of serum osmolality or overly aggressive fluid administration in children. Current pediatric DKA guidelines recommend gradual fluid replacement over 48 hours and cautious monitoring of osmolality change to minimize this risk. Management includes immediate reduction in fluid rate and intravenous mannitol or hypertonic saline. Recognizing these early neurological warning signs allows prompt intervention to prevent herniation and death.

• B. Hypoglycemia causes drowsiness but typically presents with tachycardia and sweating, not bradycardia with hypertension.
• C. Hypokalemia causes arrhythmias and muscle weakness, not the specific pattern of rising blood pressure with falling heart rate.
• D. Meningitis would typically have fever and meningeal signs and is not a recognized complication of DKA treatment timing.

This is the classic salt-wasting form of congenital adrenal hyperplasia due to 21-hydroxylase deficiency, the most common cause of ambiguous genitalia in genetic females. Impaired cortisol and aldosterone synthesis leads to shunting of precursors toward androgen production, causing virilization in utero, while aldosterone deficiency causes the hyponatremia, hyperkalemia, and hypovolemic shock seen in the salt-wasting crisis around day 7-14 of life. Markedly elevated 17-hydroxyprogesterone, the substrate accumulating before the enzymatic block, confirms the diagnosis. Immediate treatment with intravenous saline, glucose, and hydrocortisone is life-saving.

• A. Panhypopituitarism causes hypoglycemia and micropenis in males but does not cause virilized genitalia or this electrolyte pattern with elevated 17-hydroxyprogesterone.
• B. Androgen insensitivity syndrome causes undervirilized genitalia in a genetically male (46,XY) infant, not virilization, and does not cause salt-wasting crisis.
• C. Mixed gonadal dysgenesis presents with asymmetric or discordant gonadal development, not this classic biochemical salt-wasting pattern.

The combination of a spiral fracture inconsistent with the stated low-energy fall, a patterned loop-mark bruise, and circular burn scars constitutes a constellation highly suspicious for inflicted injury (non-accidental trauma). Physicians have an ethical and legal mandatory duty to report suspected child abuse to child protection or relevant authorities regardless of parental objection or consent, since the priority is the child's safety. Saudi child protection regulations, aligned with international standards, require health care providers to report such cases promptly rather than relying on caregiver explanation alone. Failure to report exposes the child to ongoing risk and the physician to professional and legal liability.

• B. Advising increased supervision does not address the likelihood of abuse and leaves the child at continued risk.
• C. Discharging without addressing the suspicious injury pattern fails the duty to protect the child and ignores a mandatory reporting obligation.
• D. Reporting suspected abuse to protect a child does not require parental consent, since the parent may be the perpetrator or protecting one.

When a life-threatening condition in a child can be effectively treated and the parents refuse a necessary intervention such as blood transfusion, the physician's duty is to act in the best interest of the child, who cannot consent or refuse on his own behalf. Parental authority over medical decisions does not extend to refusing life-saving treatment for a minor; courts and professional bodies, including Saudi MOH policy, support overriding such refusal in emergencies. The physician should proceed with transfusion while ideally seeking urgent institutional or legal backing, but this must not delay life-saving care. A liability waiver does not make withholding necessary treatment ethically or legally acceptable.

• B. The patient is hemodynamically unstable with ongoing blood loss; delaying life-saving treatment for an ethics committee meeting is inappropriate in a true emergency.
• C. Respecting the refusal would allow a preventable death from hemorrhagic shock, which is not ethically justified when the child's life can be saved.
• D. A liability waiver does not override the physician's duty to provide necessary care to the child and does not make withholding treatment acceptable.

APGAR scoring assigns 0-2 points each for heart rate, respiratory effort, muscle tone, reflex irritability, and color. Heart rate >100 beats/min = 2, slow irregular breathing = 1, some flexion = 1, grimace = 1, and acrocyanosis (pink body, blue extremities) = 1, giving a total of 6. The score is assessed routinely at 1 and 5 minutes, with further assessments every 5 minutes if the score remains below 7.

• B. This overcounts multiple components; acrocyanosis and incomplete tone each score only 1, not 2.
• C. This undercounts the heart rate component, which scores 2 since the rate exceeds 100 beats/min.
• D. This overcounts one component; the correct sum of the five components is 6.

According to the Neonatal Resuscitation Program algorithm, positive pressure ventilation should be started if the infant has apnea, gasping, or a heart rate below 100 beats/min after the initial steps (warming, drying, stimulating, positioning, clearing the airway). This infant meets both criteria. Chest compressions are only indicated if the heart rate remains below 60 beats/min despite 30 seconds of effective PPV. Epinephrine is reserved for persistent bradycardia below 60 beats/min despite adequate PPV and chest compressions.

• A. Further stimulation delays definitive treatment; a heart rate below 100 beats/min with poor respiratory effort requires immediate PPV.
• B. Chest compressions are indicated only when the heart rate stays below 60 beats/min despite effective ventilation, not at this stage.
• D. Epinephrine is a later step reserved for refractory bradycardia unresponsive to ventilation and compressions.

Respiratory distress syndrome results from surfactant deficiency, which is common in preterm infants and in those delivered by elective cesarean section before the onset of labor, as labor promotes surfactant release. The chest X-ray finding of diffuse fine granular ('ground-glass') opacities with air bronchograms and reduced lung volumes is classic for RDS. Transient tachypnea of the newborn typically shows hyperinflation with perihilar streaking and resolves within 24-72 hours. The gestational age, mode of delivery, and radiographic pattern together point to RDS rather than the other options.

• A. Transient tachypnea typically shows hyperinflated lungs with perihilar streaking and fluid in the fissures, not granular opacities with low lung volumes.
• B. Congenital pneumonia usually shows patchy or lobar infiltrates with a history of maternal risk factors such as prolonged rupture of membranes or chorioamnionitis.
• D. Meconium aspiration syndrome occurs in term or post-term infants with meconium-stained fluid and shows patchy infiltrates with hyperinflation.

Antenatal corticosteroids (betamethasone or dexamethasone) given to mothers in preterm labor between 24 and 34 weeks of gestation accelerate fetal lung maturation by stimulating surfactant production, significantly reducing the incidence and severity of respiratory distress syndrome, intraventricular hemorrhage, and neonatal mortality. A single course given intramuscularly is standard; the full effect is seen within 24-48 hours of the first dose. Surfactant cannot be given to the mother; it is administered directly to the neonate after birth if needed. Magnesium sulfate is given for fetal neuroprotection in very preterm labor but does not reduce the risk of RDS.

• A. Surfactant is administered directly to the neonate's lungs after delivery, not to the mother antenatally.
• B. Prophylactic antibiotics are not routinely indicated here as there is no evidence of infection or ruptured membranes.
• D. Magnesium sulfate reduces the risk of cerebral palsy in very preterm infants but does not prevent respiratory distress syndrome.

Current neonatal resuscitation guidelines no longer recommend routine tracheal suctioning for non-vigorous infants born through meconium-stained fluid, as evidence does not show improved outcomes and it delays initiation of ventilation. The initial steps of resuscitation (drying, warming, stimulating, positioning, clearing the airway if obviously obstructed) should be performed, followed promptly by positive pressure ventilation if the infant remains apneic or bradycardic. Tracheal intubation for suctioning is reserved only for infants with evidence of airway obstruction during ventilation attempts. Routine surfactant administration is not indicated unless the infant develops respiratory distress consistent with meconium aspiration syndrome.

• A. Routine suctioning does not change outcomes and should not delay initiation of the standard resuscitation sequence.
• B. Routine tracheal suctioning before initiating standard resuscitation steps is no longer recommended as it delays ventilation without proven benefit.
• D. Surfactant is not given empirically; it is reserved for infants who develop respiratory distress from aspiration, and intubation is not the first step.

Hour-specific bilirubin nomograms (such as those used in AAP and Saudi MOH neonatal guidelines) define risk zones and phototherapy thresholds based on the infant's age in hours and risk factors. A total bilirubin of 290 micromol/L at 60 hours in a low-risk term infant meets the threshold for starting phototherapy to prevent further bilirubin rise and reduce the risk of kernicterus. Exchange transfusion is reserved for bilirubin levels far above the phototherapy threshold or when there are signs of acute bilirubin encephalopathy, which this infant does not have. Discharge without treatment risks further bilirubin rise and potential neurotoxicity.

• A. Discharging without treatment risks progression toward dangerous bilirubin levels and possible kernicterus.
• B. Intravenous immunoglobulin is used in Rh or ABO hemolytic disease with ongoing hemolysis despite phototherapy, not in a Coombs-negative infant.
• C. Exchange transfusion is reserved for bilirubin levels at or above the exchange transfusion threshold or with signs of encephalopathy, well above the phototherapy level.

The direct Coombs (direct antiglobulin) test detects antibodies bound to the surface of the infant's red blood cells and is the key confirmatory test for ABO or Rh hemolytic disease of the newborn. In this scenario, an O-positive mother and an A-positive infant with early-onset jaundice raises suspicion for ABO incompatibility, and a positive direct Coombs test confirms antibody-mediated hemolysis. Reticulocyte count and peripheral smear can support the diagnosis by showing signs of hemolysis but do not confirm the immune mechanism. Haptoglobin is a nonspecific marker of hemolysis and is not the test of choice to confirm immune-mediated disease.

• A. Reticulocyte count indicates increased red cell production in response to hemolysis but does not identify the immune mechanism.
• B. Peripheral smear may show spherocytes suggestive of hemolysis but cannot confirm antibody-mediated destruction.
• C. Haptoglobin level is a nonspecific marker of hemolysis and does not confirm an immune-mediated cause.

Typical gross motor milestones progress from sitting without support (6-8 months), to crawling (8-10 months), to pulling to stand and cruising (9-12 months), with independent walking expected between 12-15 months. A 10-month-old who sits unsupported, crawls, and pulls to stand is progressing exactly along the expected sequence. Independent walking is not expected until at least 12 months, so its absence at 10 months is not delayed. Reassurance and continued developmental surveillance are appropriate.

• B. Neurology referral is not indicated because there is no delay; walking is not expected until 12-15 months.
• C. The child is meeting, not exceeding, expected milestones for a 10-month-old.
• D. Physiotherapy is unnecessary since the child is meeting milestones appropriate for his age.

Absence of single meaningful words and lack of pointing or gestures by 18 months are recognized red flags for language delay and possible autism spectrum disorder. The first priority is to rule out hearing loss, a common and reversible cause of apparent language delay, through formal audiological testing, combined with a structured developmental evaluation. Red-flag language delay should never simply be observed further, as early intervention improves outcomes. Speech therapy may follow but should not substitute for first identifying the underlying cause, particularly hearing impairment.

• A. Watchful waiting is inappropriate when red-flag features for language delay are present; early referral improves outcomes.
• B. Speech therapy should follow, not replace, assessment for a cause such as hearing loss.
• D. Brain MRI is not a first-line investigation for isolated language delay without other neurological signs.

This infant has a good appetite and normal social interaction but poor weight gain with steatorrhea, pointing to an organic cause related to malabsorption such as cystic fibrosis or celiac disease rather than inadequate intake. Non-organic failure to thrive typically involves psychosocial factors, poor feeding interaction, or caregiver difficulties, none of which are present here. The combination of adequate intake, normal feeding environment, and abnormal greasy stools indicates a gastrointestinal or pancreatic disorder impairing nutrient absorption. Further workup should include stool fat studies and sweat chloride testing.

• A. Caloric intake is described as adequate (eager feeding), making inadequate intake an unlikely explanation.
• C. Feeding technique is observed to be adequate, and the stool findings point to malabsorption rather than a feeding problem.
• D. There is no evidence of neglect; feeding technique and home environment are reported as adequate.

Lack of eye contact, failure to respond to name, repetitive non-functional play, absence of two-word phrases by 24 months, and distress with routine changes are classic red flags for autism spectrum disorder. With a normal hearing screen already excluding a sensory cause for language delay, the appropriate next step is referral for a comprehensive developmental and autism-specific evaluation, ideally using a validated screening tool followed by multidisciplinary assessment. Early identification and intervention are associated with better long-term outcomes. Genetic testing may be considered as part of a broader workup after the diagnosis is confirmed, but it is not the initial step.

• A. Stimulant medication is used for attention deficit hyperactivity disorder, not for the core features described, and medication is not an appropriate diagnostic step.
• B. These features are recognized red flags, not normal variants, and delaying assessment misses the window for early intervention.
• C. Genetic testing may be part of the later workup but is not the initial step before a developmental and autism-specific evaluation.

The World Health Organization and Saudi Ministry of Health recommend exclusive breastfeeding for the first 6 months of life, with introduction of nutritionally adequate and safe complementary foods at 6 months while continuing breastfeeding up to 2 years of age or beyond. Introducing solids before 6 months increases the risk of gastrointestinal infections and does not confer nutritional benefit in a healthy, well-growing infant. Delaying complementary feeding beyond 6 months risks nutrient deficiencies, particularly iron, as breast milk alone becomes insufficient after this age. This infant is growing appropriately and has no indication for earlier or later introduction of solids.

• A. Introducing complementary foods at 4 months is earlier than the recommended 6-month mark and is not supported by current guidelines for a healthy infant.
• B. Delaying complementary foods until 12 months risks nutrient deficiencies, as breast milk alone is insufficient after 6 months.
• D. Starting solids at 3 months is too early and increases infection risk without nutritional benefit for a well-growing infant.

In nutritional vitamin D deficiency rickets, low 25-hydroxyvitamin D reduces intestinal calcium absorption, leading to hypocalcemia, which stimulates secondary hyperparathyroidism. Elevated parathyroid hormone acts on the renal tubules to increase phosphate excretion, causing hypophosphatemia and elevated urinary phosphate, while also increasing bone turnover reflected by high alkaline phosphatase. This combination of low 25-hydroxyvitamin D, secondary hyperparathyroidism, and renal phosphate wasting is the classic biochemical signature of nutritional rickets. The clinical findings of rachitic rosary, widened wrists, and genu varum support this diagnosis.

• A. Parathyroid hormone is elevated in nutritional rickets as a secondary response to hypocalcemia, not low.
• B. Parathyroid hormone is elevated, not normal or low, as a compensatory response to hypocalcemia in vitamin D deficiency.
• C. High 25-hydroxyvitamin D would not cause hypocalcemia and secondary hyperparathyroidism, which are present in this case.

Excessive cow's milk intake in toddlers is a well-recognized cause of iron deficiency anemia through several mechanisms: cow's milk is low in iron and its iron has poor bioavailability, high milk volume displaces iron-rich solid foods from the diet, and milk protein can cause low-grade occult gastrointestinal blood loss in some infants. This produces a microcytic, hypochromic anemia with pencil cells and anisocytosis on smear, classic for iron deficiency. Management includes reducing milk intake to under 500 mL per day, introducing iron-rich foods, and iron supplementation. This is one of the most common nutritional anemias in toddlers worldwide, including in Saudi Arabia.

• B. Cow's milk protein allergy can cause gastrointestinal blood loss but does not typically cause autoimmune hemolysis; the smear findings here are consistent with iron deficiency, not hemolysis.
• C. Pasteurization does not destroy folate significantly, and folate deficiency causes macrocytic anemia, inconsistent with the microcytic picture described.
• D. Cow's milk is actually a source of vitamin B12, and B12 deficiency would cause macrocytic, not microcytic, anemia.